tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

HK:2162 Stock Latest News

Keymed Biosciences Announces Successful AGM Resolutions
Company AnnouncementsKeymed Biosciences Announces Successful AGM Resolutions
23d ago
2162
Keymed Biosciences Completes Share Placement and Subscription, Raising HK$853.77 Million
PremiumCompany Announcements
Keymed Biosciences Completes Share Placement and Subscription, Raising HK$853.77 Million
30d ago
2162
Keymed Biosciences Announces Share Placement and Subscription to Raise HK$853.77 Million
PremiumCompany Announcements
Keymed Biosciences Announces Share Placement and Subscription to Raise HK$853.77 Million
1M ago
2162
Keymed Biosciences Announces 2025 Annual General Meeting and Key Resolutions
PremiumCompany Announcements
Keymed Biosciences Announces 2025 Annual General Meeting and Key Resolutions
3M ago
2162
Keymed Biosciences to Review Annual Results and Dividend
PremiumCompany Announcements
Keymed Biosciences to Review Annual Results and Dividend
4M ago
2162
Keymed Biosciences Gains Approval for Stapokibart in Allergic Rhinitis Treatment
PremiumCompany AnnouncementsKeymed Biosciences Gains Approval for Stapokibart in Allergic Rhinitis Treatment
5M ago
2162
Keymed Biosciences Licenses CM355 to Prolium for Global Development
Premium
Company Announcements
Keymed Biosciences Licenses CM355 to Prolium for Global Development
6M ago
2162
Keymed Biosciences Secures Licensing Deal for CM313
Premium
Company Announcements
Keymed Biosciences Secures Licensing Deal for CM313
6M ago
2162
Keymed Biosciences Gains NMPA Approval for Stapokibart
PremiumCompany Announcements
Keymed Biosciences Gains NMPA Approval for Stapokibart
7M ago
2162
Keymed Biosciences Relocates Hong Kong Headquarters
PremiumCompany Announcements
Keymed Biosciences Relocates Hong Kong Headquarters
7M ago
2162
Keymed Biosciences’ CM336 Shows Promise in Myeloma Study
PremiumCompany Announcements
Keymed Biosciences’ CM336 Shows Promise in Myeloma Study
7M ago
2162
Keymed Biosciences Expands Global Reach with CM336 Deal
PremiumCompany Announcements
Keymed Biosciences Expands Global Reach with CM336 Deal
8M ago
2162
Keymed Biosciences’ Stapokibart Wins Approval in China
PremiumCompany AnnouncementsKeymed Biosciences’ Stapokibart Wins Approval in China
10M ago
2162
Keymed Biosciences Faces Steep Revenue Decline
Premium
Company Announcements
Keymed Biosciences Faces Steep Revenue Decline
11M ago
2162
Keymed Biosciences Schedules Crucial Financial Meeting
Premium
Company Announcements
Keymed Biosciences Schedules Crucial Financial Meeting
11M ago
2162
Keymed Biosciences Strikes Global Licensing Deal
PremiumCompany Announcements
Keymed Biosciences Strikes Global Licensing Deal
1y ago
2162
Keymed Biosciences Shareholders Back All Resolutions
PremiumCompany Announcements
Keymed Biosciences Shareholders Back All Resolutions
1y ago
2162
Keymed Biosciences Reveals Promising CM313 Study
PremiumCompany Announcements
Keymed Biosciences Reveals Promising CM313 Study
1y ago
2162
Keymed’s Stapokibart Drug Advances with Priority Review
PremiumCompany Announcements
Keymed’s Stapokibart Drug Advances with Priority Review
1y ago
2162
Keymed Announces Positive Stapokibart Trial Results
PremiumCompany AnnouncementsKeymed Announces Positive Stapokibart Trial Results
1y ago
2162
Keymed Reports Promising Cancer Drug Results
Premium
Company Announcements
Keymed Reports Promising Cancer Drug Results
1y ago
2162
Keymed Biosciences’ Stapokibart Gains Priority Review
Premium
Company Announcements
Keymed Biosciences’ Stapokibart Gains Priority Review
1y ago
2162

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >